Groupama Asset Managment raised its holdings in shares of Xylem Inc. (NYSE:XYL - Free Report) by 89.6% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 16,340 shares of the industrial products company's stock after buying an additional 7,723 shares during the period. Groupama Asset Managment's holdings in Xylem were worth $2,206,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Bangor Savings Bank lifted its position in shares of Xylem by 56.7% in the 3rd quarter. Bangor Savings Bank now owns 235 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 85 shares in the last quarter. Mark Sheptoff Financial Planning LLC purchased a new stake in shares of Xylem in the 2nd quarter valued at approximately $33,000. Blue Trust Inc. lifted its position in Xylem by 1,185.7% in the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company's stock worth $35,000 after buying an additional 249 shares in the last quarter. Assetmark Inc. boosted its stake in shares of Xylem by 3,887.5% during the 3rd quarter. Assetmark Inc. now owns 319 shares of the industrial products company's stock valued at $43,000 after buying an additional 311 shares during the period. Finally, Catalyst Capital Advisors LLC boosted its stake in shares of Xylem by 226.0% during the 3rd quarter. Catalyst Capital Advisors LLC now owns 339 shares of the industrial products company's stock valued at $46,000 after buying an additional 235 shares during the period. 87.96% of the stock is currently owned by institutional investors.
Xylem Price Performance
Xylem stock traded up $3.43 on Monday, reaching $129.80. The company's stock had a trading volume of 1,030,836 shares, compared to its average volume of 1,229,093. The business's fifty day moving average price is $128.67 and its 200 day moving average price is $133.03. The company has a market cap of $31.53 billion, a price-to-earnings ratio of 37.44, a PEG ratio of 2.33 and a beta of 1.05. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. Xylem Inc. has a twelve month low of $106.24 and a twelve month high of $146.08.
Xylem (NYSE:XYL - Get Free Report) last released its quarterly earnings data on Thursday, October 31st. The industrial products company reported $1.11 EPS for the quarter, meeting analysts' consensus estimates of $1.11. The business had revenue of $2.10 billion during the quarter, compared to analysts' expectations of $2.17 billion. Xylem had a net margin of 9.85% and a return on equity of 9.61%. The firm's quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.99 EPS. Equities analysts expect that Xylem Inc. will post 4.23 earnings per share for the current fiscal year.
Xylem Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be issued a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, November 26th. This represents a $1.44 annualized dividend and a yield of 1.11%. Xylem's payout ratio is 42.11%.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on XYL. Robert W. Baird decreased their target price on shares of Xylem from $175.00 to $154.00 and set an "outperform" rating for the company in a research note on Friday, November 1st. Citigroup raised shares of Xylem from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $135.00 to $148.00 in a research note on Monday. TD Cowen reduced their price objective on shares of Xylem from $138.00 to $125.00 and set a "hold" rating for the company in a research note on Wednesday, November 6th. Royal Bank of Canada dropped their target price on shares of Xylem from $163.00 to $162.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. Finally, UBS Group started coverage on shares of Xylem in a report on Tuesday, August 13th. They set a "buy" rating and a $165.00 price objective on the stock. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $150.45.
Check Out Our Latest Report on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.